HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinichiro Hayashi Selected Research

Interleukin-33

1/2016Interleukin-33 from Monocytes Recruited to the Lung Contributes to House Dust Mite-Induced Airway Inflammation in a Mouse Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinichiro Hayashi Research Topics

Disease

7Lung Neoplasms (Lung Cancer)
09/2012 - 12/2003
7Neoplasms (Cancer)
09/2012 - 08/2005
6Inflammation (Inflammations)
01/2016 - 06/2003
4Dermatomyositis (Dermatopolymyositis)
01/2022 - 02/2008
4Hypertension (High Blood Pressure)
11/2016 - 01/2015
3Necrosis
01/2022 - 01/2016
3Asthma (Bronchial Asthma)
01/2016 - 01/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 03/2003
3Pneumonia (Pneumonitis)
01/2010 - 10/2005
2Atrophy
01/2022 - 01/2021
2Melanoma (Melanoma, Malignant)
01/2022 - 01/2020
2Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 01/2020
2AIDS-Related Complex (ARC)
04/2013 - 11/2012
2Adenocarcinoma
09/2012 - 07/2010
2Fibrosis (Cirrhosis)
05/2012 - 11/2011
2Adenocarcinoma of Lung
10/2011 - 06/2008
2Infections
01/2007 - 11/2002
1Neuronal intranuclear inclusion disease
01/2022
1Aspiration Pneumonia
01/2021
1Sarcopenia
01/2021
1Muscular Atrophy (Muscle Atrophy)
01/2021
1Muscular Diseases (Myopathy)
12/2020
1With Uniform Type 1 Fiber Congenital Neuromuscular Disease
12/2020
1Ophthalmoplegia (External Ophthalmoplegia)
11/2020
1Dysarthria (Spastic Dysarthria)
11/2020
1Muscle Weakness
11/2020
1Dermatitis
01/2020
1Dyspnea (Shortness of Breath)
01/2020
1Exanthema (Rash)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020
1Cytochrome-c Oxidase Deficiency
01/2019
1Renal Hypertension
03/2017
1Hyperuricemia
03/2017
1Cardiovascular Diseases (Cardiovascular Disease)
03/2017
1Obesity
11/2016
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
09/2015
1Body Weight (Weight, Body)
01/2015

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2013 - 06/2003
7Tyrosine Kinase InhibitorsIBA
01/2015 - 02/2007
4Messenger RNA (mRNA)IBA
11/2012 - 12/2003
4ErbB Receptors (EGF Receptor)IBA
09/2012 - 06/2008
3UbiquitinIBA
01/2022 - 01/2020
3SaltsIBA
11/2016 - 01/2015
3Biomarkers (Surrogate Marker)IBA
04/2013 - 11/2008
3DNA (Deoxyribonucleic Acid)IBA
09/2012 - 08/2005
2Staphylococcal Protein A (Protein A)IBA
01/2022 - 01/2020
2EnzymesIBA
01/2022 - 01/2020
2nuclear matrix protein 2IBA
01/2022 - 01/2020
2Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2022 - 01/2021
2Mi-2 antibodiesIBA
01/2022 - 01/2021
2Alkaline PhosphataseIBA
01/2022 - 01/2021
2AntibodiesIBA
01/2022 - 11/2020
2AutoantibodiesIBA
01/2021 - 01/2020
2Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
04/2013 - 11/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
04/2013 - 11/2012
2activity regulated cytoskeletal-associated proteinIBA
04/2013 - 11/2012
2GalactokinaseIBA
04/2013 - 11/2012
2Monoclonal AntibodiesIBA
09/2011 - 07/2010
2hnRNP A2IBA
11/2008 - 08/2005
2Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
11/2008 - 08/2005
2RNA-Binding Proteins (RNA-Binding Protein)IBA
11/2008 - 08/2005
2Gefitinib (Iressa)FDA Link
06/2008 - 02/2007
2Cisplatin (Platino)FDA LinkGeneric
01/2008 - 03/2003
2Anti-Bacterial Agents (Antibiotics)IBA
08/2007 - 11/2002
2antileukinateIBA
10/2005 - 06/2003
1Nucleosomes (Nucleosome)IBA
01/2022
1Coloring Agents (Dyes)IBA
01/2022
1transcriptional intermediary factor 1IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1HLA-DR Antigens (HLA-DR)IBA
01/2022
1Histone Deacetylases (Histone Deacetylase)IBA
01/2022
1Succimer (Dimercaptosuccinic Acid)FDA Link
01/2022
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2021
1ChromatinIBA
01/2021
1Factor V (Coagulation Factor V)IBA
01/2021
1tamibaroteneIBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2020
1triadinIBA
12/2020
1Ubiquitinated ProteinsIBA
11/2020
1tiotropium-olodaterolIBA
01/2020
1Tiotropium Bromide (Spiriva)FDA Link
01/2020
1Janus Kinase InhibitorsIBA
01/2020
1Bronchodilator Agents (Bronchodilators)IBA
01/2020
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2019
1Uricosuric AgentsIBA
03/2017
1BenzbromaroneIBA
03/2017
1FebuxostatFDA Link
03/2017
1Uric Acid (Urate)IBA
03/2017
1Liposomes (Liposome)IBA
01/2016
1Thymic Stromal LymphopoietinIBA
01/2016
1Clodronic Acid (Clodronate)IBA
01/2016
1Interleukin-33IBA
01/2016
1DystrophinIBA
09/2015

Therapy/Procedure

4Therapeutics
01/2020 - 01/2008
2Aftercare (After-Treatment)
01/2020 - 01/2007
1Artificial Respiration (Mechanical Ventilation)
01/2021